Dr. Joel Cherdack has spent more than two decades watching patients arrive at the same crossroads. The pain has become unmanageable. Conservative treatments — physical therapy, cortisone injections, anti-inflammatories — have stopped working or never worked well enough. Surgery is on the table, and the patient is not sure they want to be on it. Cherdack founded Houston Regenerative Medicine in 2015 specifically for people standing at that crossroads, and the practice he has built with Dr. Andrew Hong, MD, is grounded in a conviction that has only grown stronger with clinical experience: the body, given the right biological tools, is often capable of repairing itself. The clinic specializes in autologous stem cell therapy and Platelet-Rich Plasma treatments — non-surgical interventions that use the patient's own biology to drive healing in damaged joints, tendons, ligaments, and cartilage. For Houston patients who have been told that surgery is their only remaining option, the work being done here represents a genuinely different answer to that question.
Houston Regenerative Medicine operates as a medical clinic — not a spa, not a wellness center, and not a franchise operation applying the same protocol to every patient who walks through the door. The practice is locally owned, FDA-compliant in its orthobiologics protocols, and equipped with an on-site lab that allows the team to assess cell viability before any treatment is administered. That level of clinical rigor is not universal in the regenerative medicine space, and it is one of the reasons the practice describes its approach as the gold standard in autologous therapy. The distinction matters to patients who are making decisions about their bodies and their health, and it matters to Cherdack and Hong, who have built their reputations on outcomes rather than promises.
For Houston residents who are living with chronic joint pain, sports injuries, or degenerative conditions and are trying to understand whether regenerative therapy is a legitimate option for their situation, here is a closer look at how the practice approaches that work — and what anyone considering this path needs to understand before they make a decision.
What Stem Cell and PRP Therapy Actually Involve — And Why the Protocol Is Everything
"The therapy is only as good as the protocol behind it," Cherdack says, and it is a point he returns to often when explaining what separates clinically rigorous regenerative medicine from the broader market of treatments that use similar language. Autologous stem cell therapy — the kind practiced at Houston Regenerative Medicine — draws cells from the patient's own body, either from bone marrow or adipose tissue, processes them in an on-site lab, and reintroduces them at the site of injury or degeneration. Because the cells come from the patient, there is no risk of rejection and no reliance on donor material of uncertain origin. The body is, in the most literal sense, healing itself.
PRP therapy follows a related logic. A sample of the patient's blood is drawn, centrifuged to concentrate the platelets and growth factors, and injected into the affected area. Platelets are the body's first responders to tissue damage — they signal repair, recruit healing cells, and initiate the biological cascade that drives recovery. Concentrating them and delivering them precisely to the site of injury accelerates a process the body is already designed to perform.
The practice's signature acCELLerate™ protocol combines plasma, platelets, and stem cells into a single treatment designed to maximize the biological signals driving repair. For patients with complex presentations — severe cartilage loss, degenerative disc disease, chronic tendon injuries — this layered approach delivers a more comprehensive healing environment than any single component alone. Dr. Hong brings the medical oversight that ensures each treatment plan is calibrated to the patient's specific imaging, history, and clinical presentation. "No two patients are the same," Cherdack explains, "and no two treatment plans should be either."
The conditions the clinic addresses span the range of musculoskeletal complaints that most commonly bring patients to the crossroads between ongoing pain and surgical intervention: knee osteoarthritis, rotator cuff tears, hip degeneration, degenerative disc disease, chronic back pain, Achilles tendon injuries, and complex ligament damage, among others. The clinic also treats neuropathy and offers hormone replacement therapy — including bioidentical hormones and testosterone therapy — for patients whose quality of life is being affected by hormonal decline. These are not unrelated offerings. They reflect a practice philosophy that treats the patient as a whole person, not a collection of isolated complaints.
What This Means for Patients in Houston
Houston is a city that moves fast and sits for long stretches — a combination that creates a specific pattern of musculoskeletal wear that Cherdack has observed consistently across his patient population. The practice has a name for one of the most common presentations it sees: "Beltway Back," the chronic lumbar compression that accumulates in executives, commuters, and professionals who spend hours each day in a car or at a desk. It is not a dramatic injury. It is the slow, grinding consequence of a lifestyle that the body was not designed to sustain indefinitely, and it does not respond well to treatments designed for acute trauma.
Houston's climate adds another layer. The city's humidity is a genuine physiological variable — it affects inflammation, joint fluid viscosity, and the way chronic conditions present and progress. Patients who have moved to Houston from drier climates frequently notice that conditions they had managed adequately elsewhere become more symptomatic here. Cherdack and Hong factor these environmental realities into how they approach treatment planning, because a protocol that ignores the patient's daily context is a protocol that is working with incomplete information.
The practice serves patients across the Houston metro area — from The Woodlands to River Oaks, from Katy to the Medical Center corridor — and the range of people who find their way to the clinic reflects the breadth of what regenerative therapy can address. Athletes sidelined by rotator cuff tears or Jumper's Knee. Executives whose chronic back pain has begun to affect their professional performance. Older patients who have been told their knee osteoarthritis has progressed to the point where replacement is the only remaining option. Each of these patients arrives with a different story and a different definition of what recovery looks like — and the practice's commitment to individualized treatment planning is what allows it to serve all of them effectively.
The clinic's on-site lab is worth understanding in this context. Cell viability — the measure of how biologically active the harvested cells are before they are reintroduced — is a variable that directly affects outcomes. A clinic that processes cells off-site, or that does not assess viability before treatment, is operating with less information than the procedure requires. Houston Regenerative Medicine's investment in on-site processing is not incidental. It is a clinical decision that reflects the standard of care the practice holds itself to.
here
What to Look For When Considering Regenerative Therapy
For Houston patients who are evaluating regenerative medicine as an option for their condition, a few things are worth understanding before the first consultation with any provider.
Ask specifically whether the therapy is autologous — meaning derived from your own cells — or whether it uses donor-sourced material. Autologous therapy eliminates the variables of donor compatibility and the quality uncertainty that comes with externally sourced biological products. A clinic that cannot clearly answer this question, or that uses the terms interchangeably, is telling you something important about the precision of its practice.
Ask about the clinic's lab capabilities and how cell viability is assessed. The biological quality of the material being used in treatment is a direct determinant of outcomes. A provider who harvests cells and reintroduces them without assessing their viability is skipping a step that matters clinically. On-site processing, with documented viability assessment, is the standard that serious regenerative medicine practices maintain.
Ask whether the treatment protocol is customized to your specific imaging and clinical history, or whether the clinic applies a standard protocol to all patients presenting with a given condition. Regenerative therapy is not a commodity. The concentration of cells and growth factors, the delivery method, the combination of treatment components — all of these variables should be calibrated to what your body actually needs, not to what is administratively convenient for the clinic.
Finally, ask about the provider's credentials and clinical oversight. Regenerative medicine is a field where the gap between rigorous medical practice and loosely regulated wellness offerings is significant. A clinic with licensed physicians, FDA-compliant protocols, and a track record of outcomes in the specific conditions you are dealing with is a fundamentally different proposition from one that is marketing the language of regenerative medicine without the clinical infrastructure to back it up.
The Practice Built Around What the Body Can Do
Dr. Joel Cherdack and Dr. Andrew Hong have built Houston Regenerative Medicine around a premise that is both scientifically grounded and, for many patients, genuinely hopeful: that the gap between chronic pain and surgical intervention is not as narrow as it is often presented. The body's capacity for repair, properly supported, is more robust than most patients have been led to believe — and the clinical tools now available to harness that capacity have advanced to the point where outcomes that were not achievable a decade ago are achievable today.
For Houston patients who have been living with pain and have been told that surgery is the next step, the practice offers something worth understanding before that decision is made. The consultation is where that conversation begins — a clinical assessment of whether regenerative therapy is appropriate for the specific condition, the specific patient, and the specific goals they are trying to achieve.
That conversation starts on your terms, with a team that is invested in getting the answer right rather than in moving quickly to a predetermined conclusion.